Safety and efficacy of panitumumab (pmab) in HPV-positive (+) and HPV-negative (-) recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Analysis of the global phase III SPECTRUM trial.
Jan Stoehlmacher-Williams
Consultant or Advisory Role - Amgen
Honoraria - Amgen
Research Funding - Amgen
Other Remuneration - Amgen
Cristian Villanueva
No relevant relationships to disclose
Paolo Foa
No relevant relationships to disclose
Sylvie Rottey
No relevant relationships to disclose
Eric Winquist
Consultant or Advisory Role - Amgen (U)
Lisa F. Licitra
No relevant relationships to disclose
Irina Davidenko
No relevant relationships to disclose
Krzysztof A. Skladowski
Consultant or Advisory Role - Amgen
Makoto Tahara
Consultant or Advisory Role - Merck Serono
Honoraria - Aventis; Taiho Pharmaceutical; Takeda
Research Funding - Eisai; Yakult Honsha
Sandrine J. Faivre
Honoraria - Amgen
Research Funding - Amgen
Kelly S. Oliner
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Zhiying Pan
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Bruce A. Bach
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Jan Baptist Vermorken
Consultant or Advisory Role - Amgen; Boehringer Ingelheim; Merck Serono
Honoraria - Amgen; Boehringer Ingelheim; Merck Serono